/
Managing Health Risks Health, both physical and mental, are determined by a combination Managing Health Risks Health, both physical and mental, are determined by a combination

Managing Health Risks Health, both physical and mental, are determined by a combination - PowerPoint Presentation

GoodGirlGoneBad
GoodGirlGoneBad . @GoodGirlGoneBad
Follow
348 views
Uploaded On 2022-08-03

Managing Health Risks Health, both physical and mental, are determined by a combination - PPT Presentation

Making conscious individual choices regarding improvement in ones health is a function of the level of education the surrounding social and political culture and the level of information Health insurance coverage in most countries consists of a mix of publicly funded and private health care sy ID: 933781

coronavirus health care fatalities health coronavirus fatalities care cases 2020 diseases covid impact rates effective fatality million delmarva public

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Managing Health Risks Health, both physi..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Managing Health Risks

Health, both physical and mental, are determined by a combination of personal risk choices, and levels of prevention and remediation

Making conscious individual choices regarding improvement in one’s health is a function of the level of education, the surrounding social and political culture, and the level of information

Health insurance coverage in most countries consists of a mix of publicly funded and private health care systems.

Health care is strongly affected by conditions of incomplete and often asymmetric information, which provides a foundational justification for public sector intervention

To the extent that health care is “free” to the individual user, there is less of an incentive to adopt prudential health care practices, and instead to rely on public and private health insurance to cover remedial treatment

Designing effective public health care choices depends in the final analysis on the choice of economic incentives and the extent to which they are structured in a credible and transparent fashion to users.

Slide2

Chronic, epidemic, and pandemic diseases in historical perspective

Chronic diseases

– organ failure (heart, liver, kidney), sickle cell anemia, cancer, AIDS, and tuberculosis are significant diseases. Some fatalities are due to genetic inheritance while others are due to lifestyle choices (smoking, drinking, inadequate exercise, lack of a healthy diet). Chronic diseases are mostly non-infectious, though some such as tuberculosis, and AIDS are infectious.

Epidemic diseases –infectious diseases that affect groups of population at specific moments in time (flu, malaria, typhoid, yellow fever, Ebola, SARS, and meningitis)Pandemic diseases – infectious diseases that strike whole populations at large regardless of the type or characteristics of the carrier or those infected.

Slide3

Episodes of epidemic, and pandemic diseases in historical perspective

Plague of Athens

, 430 BC – 100,000 fatalities, coinciding with the Peloponnesian War between Athens and Sparta, and may have affected the outcome of the war.

Antonine Plague, 165-180 A.D. – estimates of as many as 5 million dead throughout the Roman Empire. St. Cyprian Plague, 250-271 AD. As many as 25,000,00 may have died throughout the Roman Empire.Plague of Justinian 527-565 AD – 600,000 fatalities.

The Black Death

1346-1353 – 25 million fatalities

Cocoliztli Epidemic

1545-1548 – 15 million fatalities in Mexico and Central America

Great Plague of London

1665-66 – 100,000 fatalities

1890 Influenza

– 1 million fatalities

1918 Influenza

– 100 million fatalities worldwide

AIDS 1981-Preant

– 35 million fatalities

Slide4

The Coronavirus of 2020

The coronavirus was first documented in Wuhan, China in the fall of 2019

Similar to H1N1 viruses and given the name COVID-19 to reflect its difference with previous viruses of the same category

While a search for a vaccine began as early as December 2019, only starting in December have production versions by Pfizer and Moderna become commercially available.In the meantime, reliance on facial masks and social distancing, along with testing and contact tracing remain the most effective responses to the virus until universal vaccination has been accomplished.

Profiles of International, national, and regional areas reflect differences in policy consistency, implementation, and follow-up

Slide5

Tracking The Coronavirus of 2020

Slide6

The U.S. Accounts for between a Quarter and a Fifth of Global Coronavirus Cases

Slide7

Tracking International Coronavirus Fatality Rates in 2020

Slide8

Tracking Regional Coronavirus Cases in 2020

Slide9

Tracking Regional Coronavirus Fatality Rates in 2020

Slide10

Delmarva Coronavirus Cases in 2020

Slide11

Tri-State Shares of Coronavirus Cases in 2020

Slide12

Delmarva State Shares of Coronavirus Cases in 2020

Slide13

Delmarva Coronavirus Fatality Rates in 2020

Slide14

The Case Frequency Impact of Coronavirus on Minorities

Slide15

The Impact of Coronavirus on Minorities

Slide16

The Population Age Impact of Coronavirus Fatalities

Slide17

The Gender Impact of Coronavirus Fatalities

Slide18

Assessing the Impact of Coronavirus Fatalities

Slide19

Assessing the Impact of Coronavirus Fatalities

The United States has the highest single number of COVID cases and fatalities, accounting for betwe3n 20 and 25 percent of the total of each since records were kept in March, 2020

Variations in international COVID case shares reflect a function of public policies to contain the virus – testing, tracing, face mask wearing, social distancing, and accelerated development and distribution of effective vaccines.

Maryland and Delaware fatality rates exceed those in the U.S. and the world average though lately at a lower rate. Overall fatality rates have been declining as responsive measures have been put into place.

Slide20

Assessing the Impact of The Coronavirus, continued

Though smaller in population, Maryland has more cases than Virginia.

Maryland Eastern Shore counties have a dominant share of COVID cases on Delmarva

Newcastle, Sussex, and Kent counties in Delaware have higher case rates than for other counties on Delmarva.

Northampton county, Virginia and Kent County, Maryland have higher fatality rates than for Delmarva as a whole

COVID cases fall disproportionately on African-Americans and Hispanic origin residents, as do fatalities

COVID fatalities fall disproportionately among the elderly

COVID cases fall roughly equally between Men and Women, as do fatalities.

Slide21

The Costs of Delay and Accountability are Substantial

Slide22

Health Care Expenditure Share of U.S. GDP

Slide23

International Health Care Expenditure and Life Expectancy

Slide24

U.S. Health Care Expenditure by Financing Source

Slide25

Sources of U.S. Health Care Financing

Slide26

Evolution of U.S. Health Care Funding Sources

Slide27

The Need for a Comprehensive Science-based Health Care Strategy for Sustainable Health

While there do not appear to be significant differences between countries with more centralized than decentralized government, there are differences in terms of the extent to which government designs and implements an effective national strategy.

China, where the COVID-19 virus is thought to have originated, has implemented severe lockdowns to bring infections under control. Elsewhere, countries are less governed by authoritarian regimes, thereby complicating the articulation of effective strategies

In Japan, and South Korea, along with India, more democratic institutions have prevailed in helping to contain the spread of the virus. It is in these countries where effective strategies might provide models for application elsewhere.In all cases, a combination of economic incentives and a coherent national strategy built on inclusion and democratic transparency are keys to success, a framework thus far eluding many western countries.

Expanding public financing of health care without efforts to address costs will not reduce the rising share of GDP devoted to health care. The ACA addressed the use of markets to provide greater insurance coverage at lower rate through health exchanges

While the ACA expanded insurance coverage, it did not address health care costs for prescription drugs and related treatment services, and at the same time did not place emphasis on preventive health care.

The lack of health care insurance coverage mobility is one factor that reduces per capita growth in GDP. The ACA did not address this issues, though the single payer option did.